Assetmark, Inc Dr Reddys Laboratories LTD Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Assetmark, Inc holds 37,666 shares of RDY stock, worth $591,732. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,666

Previous 34,830 8.14%

Holding current value

$591,732

Previous $2.65 Million 12.78%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$75.41 - $84.21 $213,862 - $238,819	2,836 Added 8.14%	37,666 $2.99 Million
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $992,500 - $1.11 Million	-14,540 Reduced 29.45%	34,830 $2.65 Million
Q1 2024 May 06, 2024	BUY	$67.36 - $77.59 $111,750 - $128,721	1,659 Added 3.48%	49,370 $3.62 Million
Q4 2023 Feb 09, 2024	BUY	$64.27 - $69.9 $95,055 - $103,382	1,479 Added 3.2%	47,711 $3.32 Million
Q3 2023 Oct 27, 2023	BUY	$61.9 - $72.77 $2.79 Million - $3.28 Million	45,096 Added 3969.72%	46,232 $3.09 Million
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $120,495 - $142,565	-2,259 Reduced 66.54%	1,136 $71,000
Q1 2023 May 05, 2023	BUY	$51.63 - $56.93 $137,542 - $151,661	2,664 Added 364.43%	3,395 $193,000
Q4 2022 Feb 10, 2023	SELL	$51.15 - $57.45 $3,887 - $4,366	-76 Reduced 9.42%	731 $37,000
Q3 2022 Nov 01, 2022	BUY	$49.9 - $57.32 $2,894 - $3,324	58 Added 7.74%	807 $42,000
Q2 2022 Aug 03, 2022	SELL	$49.62 - $58.13 $8,633 - $10,114	-174 Reduced 18.85%	749 $41,000
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $13,225 - $17,878	274 Added 42.22%	923 $51,000
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $27,548 - $31,136	463 Added 248.92%	649 $42,000
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $1.19 Million - $1.49 Million	-19,829 Reduced 99.07%	186 $12,000
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $154,430 - $184,461	2,486 Added 14.18%	20,015 $1.47 Million
Q1 2021 May 14, 2021	BUY	$57.98 - $73.08 $180,085 - $226,986	3,106 Added 21.54%	17,529 $1.08 Million
Q4 2020 Feb 10, 2021	BUY	$62.61 - $71.29 $386,303 - $439,859	6,170 Added 74.76%	14,423 $1.03 Million
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $262,345 - $369,653	5,105 Added 162.17%	8,253 $574,000
Q2 2020 Aug 11, 2020	BUY	$39.55 - $54.65 $37,414 - $51,698	946 Added 42.96%	3,148 $167,000
Q1 2020 May 12, 2020	BUY	$34.75 - $45.85 $24,429 - $32,232	703 Added 46.9%	2,202 $89,000
Q4 2019 Feb 11, 2020	BUY	$36.66 - $41.78 $50,810 - $57,907	1,386 Added 1226.55%	1,499 $61,000
Q3 2019 Nov 13, 2019	BUY	$34.82 - $39.26 $3,795 - $4,279	109 Added 2725.0%	113 $4,000
Q4 2016 Sep 15, 2017	SELL	N/A	-19 Reduced 82.61%	4 $0
Q4 2015 Sep 15, 2017	BUY	N/A	23	23 $1,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account